Cargando…
Metabolic acidosis caused by concomitant use of paracetamol (acetaminophen) and flucloxacillin? A case report and a retrospective study
PURPOSE: A patient was identified with severe metabolic acidosis, a high anion gap and 5-oxoproline accumulation, probably caused by the simultaneous use of paracetamol (acetaminophen) and flucloxacillin. We wanted to investigate the necessity to control the interaction between both drugs with an au...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5662679/ https://www.ncbi.nlm.nih.gov/pubmed/28782093 http://dx.doi.org/10.1007/s00228-017-2311-6 |
_version_ | 1783274680476499968 |
---|---|
author | Berbee, J. K. Lammers, L. A. Krediet, C. T. P. Fischer, J. C. Kemper, E. M. |
author_facet | Berbee, J. K. Lammers, L. A. Krediet, C. T. P. Fischer, J. C. Kemper, E. M. |
author_sort | Berbee, J. K. |
collection | PubMed |
description | PURPOSE: A patient was identified with severe metabolic acidosis, a high anion gap and 5-oxoproline accumulation, probably caused by the simultaneous use of paracetamol (acetaminophen) and flucloxacillin. We wanted to investigate the necessity to control the interaction between both drugs with an automatic alert system. METHODS: To investigate the relevance of the interaction of paracetamol and flucloxacillin, a retrospective study was conducted. Data on paracetamol and flucloxacillin prescriptions and laboratory data (pH, Na(+), HCO(3) (−), Cl(−), albumin and 5-oxoproline levels) were combined to assess the prevalence of acidosis, calculate the anion gap and analyse 5-oxoproline levels in clinically admitted patients using both drugs simultaneously. RESULTS: In the 2-year study period, approximately 53,000 admissions took place in our hospital. One thousand and fifty-seven patients used paracetamol and flucloxacillin simultaneously, of which 51 patients (4.8%) had a serum pH ≤ 7.35. One patient, the same patient as presented in the case report, had a high anion gap and a toxic level of 5-oxoproline. CONCLUSION: The prevalence of metabolic acidosis is very low and the only patient identified with the interaction was recognised during normal clinical care. We conclude that automatic alerts based on simultaneous use of paracetamol and flucloxacillin will generate too many signals. To recognise patients earlier and prevent severe outcomes, a warning system (clinical rule) based on paracetamol, flucloxacillin and pH measurement may be helpful. Early calculation of the anion gap can narrow the differential diagnosis of patients with metabolic acidosis and measurement of 5-oxoproline can explain acidosis due the interaction of paracetamol and flucloxacillin. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00228-017-2311-6) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5662679 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-56626792017-11-15 Metabolic acidosis caused by concomitant use of paracetamol (acetaminophen) and flucloxacillin? A case report and a retrospective study Berbee, J. K. Lammers, L. A. Krediet, C. T. P. Fischer, J. C. Kemper, E. M. Eur J Clin Pharmacol Pharmacoepidemiology and Prescription PURPOSE: A patient was identified with severe metabolic acidosis, a high anion gap and 5-oxoproline accumulation, probably caused by the simultaneous use of paracetamol (acetaminophen) and flucloxacillin. We wanted to investigate the necessity to control the interaction between both drugs with an automatic alert system. METHODS: To investigate the relevance of the interaction of paracetamol and flucloxacillin, a retrospective study was conducted. Data on paracetamol and flucloxacillin prescriptions and laboratory data (pH, Na(+), HCO(3) (−), Cl(−), albumin and 5-oxoproline levels) were combined to assess the prevalence of acidosis, calculate the anion gap and analyse 5-oxoproline levels in clinically admitted patients using both drugs simultaneously. RESULTS: In the 2-year study period, approximately 53,000 admissions took place in our hospital. One thousand and fifty-seven patients used paracetamol and flucloxacillin simultaneously, of which 51 patients (4.8%) had a serum pH ≤ 7.35. One patient, the same patient as presented in the case report, had a high anion gap and a toxic level of 5-oxoproline. CONCLUSION: The prevalence of metabolic acidosis is very low and the only patient identified with the interaction was recognised during normal clinical care. We conclude that automatic alerts based on simultaneous use of paracetamol and flucloxacillin will generate too many signals. To recognise patients earlier and prevent severe outcomes, a warning system (clinical rule) based on paracetamol, flucloxacillin and pH measurement may be helpful. Early calculation of the anion gap can narrow the differential diagnosis of patients with metabolic acidosis and measurement of 5-oxoproline can explain acidosis due the interaction of paracetamol and flucloxacillin. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00228-017-2311-6) contains supplementary material, which is available to authorized users. Springer Berlin Heidelberg 2017-08-07 2017 /pmc/articles/PMC5662679/ /pubmed/28782093 http://dx.doi.org/10.1007/s00228-017-2311-6 Text en © The Author(s) 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Pharmacoepidemiology and Prescription Berbee, J. K. Lammers, L. A. Krediet, C. T. P. Fischer, J. C. Kemper, E. M. Metabolic acidosis caused by concomitant use of paracetamol (acetaminophen) and flucloxacillin? A case report and a retrospective study |
title | Metabolic acidosis caused by concomitant use of paracetamol (acetaminophen) and flucloxacillin? A case report and a retrospective study |
title_full | Metabolic acidosis caused by concomitant use of paracetamol (acetaminophen) and flucloxacillin? A case report and a retrospective study |
title_fullStr | Metabolic acidosis caused by concomitant use of paracetamol (acetaminophen) and flucloxacillin? A case report and a retrospective study |
title_full_unstemmed | Metabolic acidosis caused by concomitant use of paracetamol (acetaminophen) and flucloxacillin? A case report and a retrospective study |
title_short | Metabolic acidosis caused by concomitant use of paracetamol (acetaminophen) and flucloxacillin? A case report and a retrospective study |
title_sort | metabolic acidosis caused by concomitant use of paracetamol (acetaminophen) and flucloxacillin? a case report and a retrospective study |
topic | Pharmacoepidemiology and Prescription |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5662679/ https://www.ncbi.nlm.nih.gov/pubmed/28782093 http://dx.doi.org/10.1007/s00228-017-2311-6 |
work_keys_str_mv | AT berbeejk metabolicacidosiscausedbyconcomitantuseofparacetamolacetaminophenandflucloxacillinacasereportandaretrospectivestudy AT lammersla metabolicacidosiscausedbyconcomitantuseofparacetamolacetaminophenandflucloxacillinacasereportandaretrospectivestudy AT kredietctp metabolicacidosiscausedbyconcomitantuseofparacetamolacetaminophenandflucloxacillinacasereportandaretrospectivestudy AT fischerjc metabolicacidosiscausedbyconcomitantuseofparacetamolacetaminophenandflucloxacillinacasereportandaretrospectivestudy AT kemperem metabolicacidosiscausedbyconcomitantuseofparacetamolacetaminophenandflucloxacillinacasereportandaretrospectivestudy |